journal article·2017-10-10Open access

Folic acid conjugated PEG coated gold–iron oxide core–shell nanocomplex as a potential agent for targeted photothermal therapy of cancer

Habib Ghaznavi, Samira Hosseini-Nami, S. Kamran Kamrava, Rasoul Irajirad, Shayan Maleki, Ali Shakeri-Zadeh, Alireza Montazerabadi

Abstract

This study reports the synthesis and characterization of poly(ethylene glycol) coated gold@iron oxide core-shell nanoparticles conjugated with folic acid (FA-PEG-Au@IONP). Also, targeted therapeutic properties of such a nanocomplex were studied on human nasopharyngeal carcinoma cell line KB and human breast adenocarcinoma cell line MCF-7 in vitro. The synthesized nanocomplex was characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), UV-Vis spectroscopy, vibrating sample magnetometry (VSM), and Fourier transform infrared (FTIR) spectroscopy. The photothermal effects of nanocomplex on both KB and MCF-7 cell lines were studied. Cell death and apoptosis were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry using an annexin V-fluorescein isothiocyanate/propidiumiodide apoptosis detection kit. It was found that nanocomplex is spherical in shape and its size is approximately 60 nm. UV-vis spectrum showed that nanocomplex has appropriate absorption near infrared region. FTIR spectra obtained from nanocomplex before and after conjugation with FA confirmed the formation of folate conjugated nanocomplex. Significant cell lethality was observed for KB (∼62%) and MCF-7 (∼33%) cells following photothermal therapy. Also, it was found that majority of the cell deaths were related to apoptosis process. It can be concluded that, the synthesized nanocomplex is an effective and promising multifunctional nanoplatform for targeted photothermal therapy of cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Health Promotion Research Centre, Zahedan University of Medical Sciences, Zahedan, Iran;

Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran;

Department of ENT, Head and Neck Research Centre, Iran University of Medical Sciences, Tehran, Iran;

Département de chimie, faculté des sciences et technologies, Université Claude Bernard Lyon 1, Lyon, France;

Radiation Biology Research Centre, Iran University of Medical Sciences, Tehran, Iran;

Department of Medical Physics, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran

References (42)

Show source-provided references
1. 10.1007/s10103-013-1399-x10.1007/s10103-013-1399-x ↗
2. 10.1016/j.pdpdt.2012.03.00410.1016/j.pdpdt.2012.03.004 ↗
3. 10.1007/s10103-013-1414-210.1007/s10103-013-1414-2 ↗
4. 10.1007/s00432-016-2179-310.1007/s00432-016-2179-3 ↗
5. 10.1016/j.jconrel.2016.05.06210.1016/j.jconrel.2016.05.062 ↗
6. 10.7150/thno.663010.7150/thno.6630 ↗
7. 10.1039/b810240f10.1039/b810240f ↗
8. 10.1142/S179329201550048410.1142/S1793292015500484 ↗
9. 10.1002/adma.20110352110.1002/adma.201103521 ↗
10. 10.1002/ange.20060247110.1002/ange.200602471 ↗
11. 10.1021/jp070224510.1021/jp0702245 ↗
12. 10.1002/adfm.20070048210.1002/adfm.200700482 ↗
13. 10.1021/cm060300110.1021/cm0603001 ↗
14. 10.1002/smll.20080104210.1002/smll.200801042 ↗
15. 10.1016/j.actbio.2010.10.01210.1016/j.actbio.2010.10.012 ↗
16. 10.1039/c1cc10739a10.1039/c1cc10739a ↗
17. 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P ↗
18. 10.2174/092986732466617081015491710.2174/0929867324666170810154917 ↗
19. 10.1039/C5RA26215A10.1039/C5RA26215A ↗
20. 10.1109/TMAG.1981.106118810.1109/TMAG.1981.1061188 ↗
21. 10.1021/la010432310.1021/la0104323 ↗
22. 10.1021/nn203293t10.1021/nn203293t ↗
23. Shakeri-Zadeh A · Dyn Biochem Process Biotechnol Mol Biol · 2010 · 4 · 6
24. 10.3390/cancers204191110.3390/cancers2041911 ↗
25. 10.1021/bc050050z10.1021/bc050050z ↗
26. 10.1088/0957-4484/21/10/10510510.1088/0957-4484/21/10/105105 ↗
27. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
28. 10.1038/nrc156610.1038/nrc1566 ↗
29. 10.1007/s10396-014-0558-410.1007/s10396-014-0558-4 ↗
30. 10.1177/088532821453694010.1177/0885328214536940 ↗
31. 10.1039/C4TB01708K10.1039/C4TB01708K ↗
32. 10.1016/j.nano.2007.07.00110.1016/j.nano.2007.07.001 ↗
33. 10.1007/s10856-009-3895-x10.1007/s10856-009-3895-x ↗
34. 10.1039/c3tb20090f10.1039/c3tb20090f ↗
35. 10.1016/j.jphotobiol.2017.05.01210.1016/j.jphotobiol.2017.05.012 ↗
36. 10.2147/IJN.S12884410.2147/IJN.S128844 ↗
37. 10.3390/nano705011110.3390/nano7050111 ↗
38. 10.1016/j.physe.2016.03.02310.1016/j.physe.2016.03.023 ↗
39. 10.1016/j.biomaterials.2011.08.08610.1016/j.biomaterials.2011.08.086 ↗
40. 10.1038/srep2832510.1038/srep28325 ↗
41. 10.1021/acsami.6b1013210.1021/acsami.6b10132 ↗
42. 10.1186/s12951-015-0113-510.1186/s12951-015-0113-5 ↗